SIGNATUREFD, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 177 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
SIGNATUREFD, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$5,000
-28.6%
532
+54.2%
0.00%
Q4 2021$7,000
-41.7%
345
-0.6%
0.00%
Q3 2021$12,000
-7.7%
347
+6.4%
0.00%
-100.0%
Q2 2021$13,000
-31.6%
326
-17.0%
0.00%0.0%
Q1 2021$19,000
+18.8%
393
+25.6%
0.00%0.0%
Q4 2020$16,000
+100.0%
3130.0%0.00%
Q3 2020$8,000
+33.3%
3130.0%0.00%
Q2 2020$6,000
+100.0%
313
+19.0%
0.00%
Q1 2020$3,0002630.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders